Security record · archived quarter
CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare · Biotechnology
12Tracked holders
0Δ holders
51.44MShares held
$1.48BReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +3.1% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -1 | 71.70M | $2.68B | +5 | −6 |
| Q1 2026 | 93 | +2 | 73.05M | $2.65B | +9 | −7 |
| Q4 2025 | 90 | 0 | 75.54M | $3.52B | n/a | n/a |
| Q3 2025 | 15 | 0 | 56.94M | $2.37B | n/a | n/a |
| Q2 2025 | 12 | 0 | 51.44M | $1.48B | +1 | −1 |
| Q1 2025 | 9 | -2 | 19.08M | $640.10M | +2 | −4 |
| Q4 2024 | 11 | -1 | 21.01M | $1.07B | n/a | −1 |
| Q3 2024 | 11 | -2 | 14.60M | $745.98M | n/a | −2 |
| Q2 2024 | 13 | n/a | 14.80M | $663.11M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.13M | n/a | $406.26M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | The Vanguard Group ✦ (passive) | 9.26M | n/a | $266.21M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passive) | 7.42M | n/a | $213.36M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 4 | Wellington Management ✦ | 5.81M | -15.7% | $167.02M | 0.0% | ▼ Trim | 5 | SEC ↗ ×7 |
| 5 | T. Rowe Price ✦ | 5.59M | +9.3% | $160.78M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passive) | 3.22M | -1.8% | $92.73M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 2.21M | +1.0% | $63.66M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 2.00M | +156.7% | $57.47M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 737.08K | -4.7% | $21.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 653.63K | +1595.5% | $18.80M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 357.68K | +5248.0% | $10.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 52.78K | New | $1.52M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $1.52M | 0.0% |
Exited
| Marshall Wace | $307,964 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 241 holders, 121.45M shares, $4.08B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Aug 13
SC 13G/A: WELLINGTON MANAGEMENT GROUP LLP
Aug 07
SC 13G/A: FMR LLC
Aug 03
SC 13G/A: FARALLON CAPITAL MANAGEMENT, L.L.C.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API